Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

Pharma Leaders Unite to Promote Ready-to-Use Packaging Solutions, Enhancing Safety and Efficiency

(IN BRIEF) SCHOTT Pharma, Gerresheimer, and Stevanato Group have formed the “Alliance for RTU” to promote the adoption of ready-to-use (RTU) vials and cartridges within the pharmaceutical industry. This strategic alliance aims to streamline pharmaceutical manufacturing, improve operational efficiency, and … Read the full press release

Roche’s Gazyva Shows Breakthrough Results in Treating Lupus Nephritis, Offering Hope for Kidney Disease Patients

(IN BRIEF) Roche has announced positive results from its phase III REGENCY study, showing that its drug Gazyva®/Gazyvaro® (obinutuzumab) significantly outperformed standard therapy in treating active lupus nephritis. The study found that patients receiving Gazyva/Gazyvaro, in combination with standard therapies, … Read the full press release

Krka Strengthens Commitment to Sustainability with Car-Free Day and Electric Truck Initiative

(IN BRIEF) Krka employees participated in the European Mobility Week for the ninth consecutive year, promoting sustainable commuting through the company’s Car-Free Day campaign. Employees from 13 countries adopted eco-friendly travel methods such as cycling, public transport, and walking. This … Read the full press release

Pfizer and BioNTech’s Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive EU Opinion, Awaiting Approval

(IN BRIEF) Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European Medicines Agency’s (EMA) CHMP for use in individuals aged six months and older. Pending final approval from the European Commission, the vaccine will … Read the full press release

FluMist Becomes First At-Home Self-Administered Flu Vaccine Approved by FDA

(IN BRIEF) FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making it the first flu vaccine of its kind to be used at home. Adults up to 49 years old … Read the full press release

Basilea Secures USD 268 Million Agreement with BARDA to Develop Novel Antifungal and Antibacterial Treatments

(IN BRIEF) Basilea Pharmaceutica has entered into a multi-year agreement with the Biomedical Advanced Research and Development Authority (BARDA) to support the development of novel antifungal and antibacterial treatments. The agreement provides an initial USD 29 million, with the potential … Read the full press release

FDA Approves AstraZeneca’s Fasenra for Eosinophilic Granulomatosis with Polyangiitis, Offering New Hope for Patients

(IN BRIEF) AstraZeneca’s Fasenra (benralizumab) has been approved by the US FDA for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA), a rare immune-mediated vasculitis that can be fatal without treatment. The approval is based on results from the MANDARA … Read the full press release

International Consortium Invests €35 Million in Abolis Biotechnologies for Sustainable Growth

(IN BRIEF) Abolis Biotechnologies has secured €35 million from a global consortium of investors, including Evonik Venture Capital, BOLD (L’Oréal’s fund), and the DeepTech & Climate Fonds. This investment will help the company expand its biomanufacturing capabilities and bring sustainable, … Read the full press release

GSK’s mRNA Flu Vaccine Candidate Moves to Phase III After Positive Phase II Results

(IN BRIEF) GSK has reported positive results from its phase II trial for an mRNA seasonal influenza vaccine candidate, showing strong immune responses against influenza A and B strains in both younger and older adults. The trial met success criteria … Read the full press release

GSK’s Depemokimab Cuts Severe Asthma Attacks by Over 50% in Phase III Trials

(IN BRIEF) GSK’s depemokimab, a new ultra-long-acting biologic, showed a 54% reduction in severe asthma exacerbations in the SWIFT-1 and SWIFT-2 phase III trials. Administered every six months, it also demonstrated a 72% reduction in hospitalizations and emergency visits, offering … Read the full press release

AstraZeneca Pioneers Low-Impact Inhalers with Eco-Friendly Breztri Transition

(IN BRIEF) AstraZeneca has completed clinical studies to transition Breztri, its inhaled treatment for COPD, to a next-generation propellant with 99.9% lower Global Warming Potential. This change aligns with AstraZeneca’s commitment to reducing its environmental impact through its Ambition Zero … Read the full press release

Krka Commemorates 70 Years of Innovation with a New Chapter in Sculpture

(IN BRIEF) Krka celebrated its 70th anniversary by unveiling a new book with an inscription alongside its “Girl with the Growing Book” sculpture. The new book’s inscription reflects the company’s commitment to ambitious ideas, professionalism, creativity, and courage. Slovenian President … Read the full press release

Advancements in Vision Preservation: Boehringer Ingelheim’s Breakthrough in Geographic Atrophy Treatment

(IN BRIEF) Boehringer Ingelheim and CDR-Life have reported positive results from the Phase I trial of BI 771716, an investigational treatment for geographic atrophy (GA), a severe form of age-related macular degeneration. The antibody fragment met its primary safety endpoints, … Read the full press release

Basilea Pharmaceutica Reaches Milestone with Strong European Sales of Cresemba®

(IN BRIEF) Basilea Pharmaceutica Ltd announced that its antifungal drug, Cresemba® (isavuconazole), achieved significant sales in Europe, triggering a USD 25 million milestone payment from partner Pfizer. This achievement highlights Cresemba’s strong performance in treating severe fungal infections. The milestone … Read the full press release

GSK to Showcase Transformative Respiratory Research at ERS Congress 2024

(IN BRIEF) GSK will present significant research at the 2024 European Respiratory Society (ERS) Congress, including data from phase III trials of its new biologic, depemokimab, for severe asthma. The presentations highlight GSK’s commitment to advancing respiratory medicine, with a … Read the full press release

AstraZeneca to Present Key Cancer Research Breakthroughs at WCLC and ESMO 2024

(IN BRIEF) AstraZeneca will present significant cancer research at the 2024 World Conference on Lung Cancer (WCLC) and the European Society for Medical Oncology (ESMO) Congress. Highlights include new data on the effectiveness of Imfinzi in bladder cancer, a novel … Read the full press release

Sanofi’s Tolebrutinib Shows Breakthrough Potential in Slowing Disability Progression for Multiple Sclerosis Patients

(IN BRIEF) Sanofi’s phase 3 study for its drug tolebrutinib has shown promising results in treating non-relapsing secondary progressive multiple sclerosis (nrSPMS), a condition with no current approved therapies. The HERCULES study revealed that tolebrutinib successfully delayed disability progression in … Read the full press release

Roche’s PiaSky Approved in EU as First Monthly Self-Administered Treatment for PNH

(IN BRIEF) Roche has received approval from the European Commission for PiaSky® (crovalimab), a novel treatment for paroxysmal nocturnal haemoglobinuria (PNH), making it the first monthly subcutaneous (SC) treatment available in the European Union. PiaSky, which can be self-administered by … Read the full press release

Brenntag Strengthens Presence in Brazilian Life Science Market with Acquisition of PIC and PharmaSpecial

(IN BRIEF) Brenntag has expanded its presence in Brazil’s Life Science market with the acquisition of specialty chemicals distributors PIC and PharmaSpecial. The deal, which adds an Applications & Innovation Center and two laboratories to Brenntag’s network, will enhance its … Read the full press release

SISTO Armaturen S.A. Introduces Automated Multi-Port Valve to Revolutionize Pharmaceutical Production

(IN BRIEF) SISTO Armaturen S.A., part of the KSB Group, has developed the SISTO-CM1300, an automated multi-port valve designed to optimize pharmaceutical production processes. This valve automates the switching of fluids in cleaning and sterilization processes, reducing the risk of … Read the full press release